Market Overview

UPDATE: Stifel Nicolaus Raises PT to $36 on DeVry Following FQ2 Earnings

Related DV
Top 4 Mid-Cap Stocks In The Education & Training Services Industry With The Highest ROE
APEI Slips to Strong Sell - Analyst Blog

Stifel Nicolaus reiterated its Buy rating on DeVry (NYSE: DV) and raised the price target from $30.00 to $36.00.

Stifel Nicolaus noted, "DeVry's “transition year” is generally progressing better than expected – beating on revenue, EPS, medical volume metrics, and cost reductions. Expense shift (especially in advertising) to 2H benefited 2Q, but total costs are now expected to be down for the year. Enrollment turn at DeVry University will take time (new enrollment probably does not turn positive by year end) with 2014-2016 targeted as recovery and growth phase. We believe DV is well positioned over the intermediate/long term with focus on high demand programs (medical/technical) and solid value proposition."

DeVry closed at $26.12 on Wednesday.

Posted-In: Stifel NicolausAnalyst Color Price Target Analyst Ratings

 

Most Popular

Related Articles (DV)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free